PrTMS® Autism Studies

Peer-reviewed research and clinical studies supporting PrTMS® treatment for autism spectrum disorder.

The following studies and research documents explore the effectiveness of PrTMS® (Personalized Repetitive Transcranial Magnetic Stimulation) in treating patients with Autism Spectrum Disorder, including pediatric patients. Dr. Kevin T. Murphy and his team have contributed to and compiled this body of research to support evidence-based treatment.

PrTMS® in Pediatric Patients with Autism

A clinical study examining the effects of Personalized Repetitive Transcranial Magnetic Stimulation in pediatric patients diagnosed with Autism Spectrum Disorder. This study documents outcomes across multiple treatment sessions guided by EEG brainwave analysis.

Contact us to request access to this study.

Pilot Study of PrTMS®

A pilot study investigating the safety and efficacy of PrTMS® as a novel, personalized approach to transcranial magnetic stimulation. The study includes brainwave-guided treatment protocols and outcome measurements across a diverse patient population.

Contact us to request access to this study.

PrTMS® for Autism Spectrum Disorder

A comprehensive study on the application of PrTMS® for patients with Autism Spectrum Disorder. This research documents improvements in social engagement, communication, and behavioral outcomes following a structured PrTMS® treatment protocol.

Contact us to request access to this study.

Autism — SAGE Journals Publication

A peer-reviewed publication in SAGE Journals examining transcranial magnetic stimulation approaches for autism. This study contributes to the growing body of scientific literature supporting non-invasive brain stimulation as a therapeutic option for ASD.

Contact us to request access to this study.

Interested in PrTMS® Treatment?

Our team is ready to discuss whether PrTMS® is right for you or your child. Contact us today to schedule a consultation with Dr. Kevin T. Murphy.

*TMS is FDA-approved for MDD, OCD, and anxious-depression in adults and MDD in adolescents 15–21. The studies referenced on this page are provided for informational purposes. Please consult with a qualified medical professional to determine if PrTMS® is appropriate for your specific situation.

Ultimate Brain Health